Prabhav Tella, MD
Pain Medicine · Orlando, FLNPI 1013942358
Payments from drug & device makers
Across 101 payments — averaging $50.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Relievant Medsystems, Inc.$1K
- Vertos Medical, Inc.$606
- Boston Scientific$533
- Medtronic$423
- Electronic Waveform Lab, Inc.$175
- plus $784 from 16 others
What the payments were for
- Speaking & faculty fees$1,18623%
- Travel & lodging$72614%
- Food & beverage$3,21663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 17 | $1,558 |
| Relievant Medsystems, Inc. | 10 | $1,049 |
| Vertos Medical, Inc. | 9 | $606 |
| Boston Scientific | 24 | $533 |
| Medtronic(2 entities) | 11 | $423 |
| Electronic Waveform Lab, Inc. | 1 | $175 |
| AbbVie | 6 | $146 |
| GRT US Holding, Inc. | 2 | $132 |
| Stryker | 1 | $131 |
| Protega Pharmaceutials Inc | 2 | $48 |
| Curonix LLC | 3 | $43 |
| Stimwave Technologies Incorporated | 3 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Abbott | 2 | $36 |
| Vertex | 1 | $30 |
| IBSA Pharma Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Spinal Simplicity, LLC | 1 | $19 |
| Si-bone, Inc. | 1 | $19 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,129 in reported general payments places this provider in the 65th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 230 | $2,479 |
| Methocarbamol | 133 | $1,758 |
| Lidocaine | 12 | $1,497 |
| Cyclobenzaprine Hcl | 180 | $1,390 |
| Tizanidine Hcl | 90 | $1,020 |
| Etodolac | 42 | $969 |
| Nabumetone | 94 | $962 |
| Pregabalin | 30 | $615 |
| Celecoxib | 26 | $513 |
| Baclofen | 25 | $379 |
| Meloxicam | 136 | $370 |
| Diclofenac Sodium | 20 | $256 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Orlando
- Cesar LassalleOrlando$1M
- Shehzad ChoudryOrlando$89K
- Taufiq AhmedOrlando$25K
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
- Joseph PergolizziNaples$2.1M
- Abel MurilloMiami$1.6M
- George MonluxPalm Coast$1.3M
- Ferdinand FormosoJacksonville$1M
- Robert GuirguisTampa$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.